Why tendons heal slowly—and how to think about recovery.
An honest, physician-informed overview of how tendons repair, what's proven to help, and where peptide research currently fits in the picture.
Tendons connect muscle to bone and carry enormous mechanical load. They have a relatively limited blood supply compared to muscle, which is a major reason they tend to heal slowly and can become persistently painful when overloaded. Tendon problems range from acute strains to chronic tendinopathy, where the tissue's structure changes over time.
The foundations of tendon recovery are well supported and should be the starting point for almost everyone:
Sleep, adequate protein, managing overall training load, and patience do a great deal of the work. These are frequently the highest-yield place to focus—and they cost nothing.
Some peptides—such as BPC-157 and TB-500—appear in preclinical research related to tissue and tendon repair. It's an active and interesting area of investigation, but human clinical evidence is still developing, and these aren't established treatments. A physician can help you understand what the research does and doesn't show, and whether it's reasonable to consider in your specific situation.
This page is educational and not medical advice. It doesn't recommend any specific therapy. Peptide research in this area is largely preclinical, and any treatment decision belongs with a licensed physician after an individual evaluation.
If pain is persistent, limiting your activity, or not improving with rest and rehabilitation, it's worth a professional evaluation—both to confirm what's going on and to discuss the full range of options.
A licensed physician can review your situation and give you honest, individualized guidance—including whether peptide therapy is even worth considering.
Start Your Evaluation →Important medical & legal information: Meridian Longevity is a physician-guided telehealth practice. Educational content on this site describes areas of scientific research; it is not an offer to sell any compound and is not medical advice. Some compounded peptide therapies are not approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Therapy is available only when a licensed physician determines it is appropriate after an individual evaluation, and is dispensed only by a licensed pharmacy against a valid, patient-specific prescription. The regulatory status of these compounds is evolving. Individual results vary.